Drug-Induced Liver Damage when Using Cephalosporins
https://doi.org/10.33647/2713-0428-20-3E-244-247
Abstract
For many years, cephalosporins have been rarely reported as drugs causing hepatotoxicity. However, the recent data points to the possible development of various types of drug-induced liver damage associated with cephalosporins, including long-term ones, which manifest themselves 1–3 weeks after a single administration.
About the Authors
I. V. Zamlelaya
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Irina V. Zamlelaya, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky Lane, 29
A. V. Safronenko
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Andrey V. Safronenko, Dr. Sci. (Med.), Prof.
344022, Rostov-on-Don, Nakhichevansky Lane, 29
N. V. Sukhorukova
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Natalya V. Sukhorukova, Cand. Sci. (Med.), Assoc. Prof.
344022, Rostov-on-Don, Nakhichevansky Lane, 29
A. V. Kapliev
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Andrey V. Kapliev, Cand. Sci. (Med.), Assoc. Prof.
344022, Rostov-on-Don, Nakhichevansky Lane, 29
A. V. Krishtopa
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Anna V. Krishtopa, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky Lane, 29
S. S. Khrkhrian
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Sofia S. Khrkhrian
344022, Rostov-on-Don, Nakhichevansky Lane, 29
References
1. Ikhambaeva A.N., Makalkina L.G., Aldiyarova N.T., Surov V.K. Bezopasnost' primeneniya antibakterial'nykh sredstv v pediatrii [Safety of antibacterial agents in pediatrics]. Neyrokhirurgiya i nevrologiya Kazakhstana [Neurosurgery and Neurology of Kazakhstan]. 2019;4(57):48–65. (In Russian).
2. Pereverzev A.P., Ostroumova O.D., Kochetkov A.I. Kholestaticheskiy variant lekarstvenno-indutsirovannogo porazheniya pecheni [Drug-induced liver damage with cholestasis]. Kachestvennaya klinicheskaya praktika [Good Clinical Practice]. 2020;3:61–74. (In Russian). DOI: 10.37489/2588-0519-2020-3-61-74
3. Alqahtani S.A., Kleiner D.E., Ghabril M., Gu J., Hoofnagle J.H., Rockey D.C.; Drug-Induced Liver Injury Network (DILIN) Study Investigators. Identification and characterization of cefazolin-induced liver injury. Clin. Gastroenterol. Hepatol. 2015;13(7):1328–1336.e2. DOI: 10.1016/j.cgh.2014.11.036
4. Barman M., Al Hariri B., Rahman Mustafa A., Ambra N., Amjed I., Eid Nazzal Alharafsheh A., Illahi M.N., Hamuda S., Gaafar M., Sharif M. Ceftriaxone-induced hepatotoxicity in patients with common medical infections in Qatar: A retrospective study. Qatar Med. J. 2022;2022(3):27. DOI: 10.5339/qmj.2022.27
5. Nakaharai K., Sakamoto Y., Yaita K., Yoshimura Y., Igarashi S., Tachikawa N. Drug-induced liver injury associated with high-dose ceftriaxone: A retrospective cohort study adjusted for the propensity score. Eur. J. Clin. Pharmacol. 2016;72(8):1003–1011. DOI: 10.1007/s00228-016-2064-7
6. Onakpoya I.J., Heneghan C.J., Aronson J.K. Postmarketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature. BMC Med. 2016;14:10. DOI: 10.1186/s12916-016-0553-2
7. Sipos M., Farcas A., Leucuta D.C., Bucsa C., Huruba M., Mogosan C. Second-generation cephalosporins-associated drug-induced liver disease: A study in VigiBase with a focus on the elderly. Pharmaceuticals (Basel). 2021;14(5):441. DOI: 10.3390/ph14050441
8. Shah T., Joslyn J.A., Lai J. Ceftazidime induced liver injury. BMJ Case Rep. 2021;14(12):e246571. DOI: 10.1136/bcr-2021-246571
Review
For citations:
Zamlelaya I.V., Safronenko A.V., Sukhorukova N.V., Kapliev A.V., Krishtopa A.V., Khrkhrian S.S. Drug-Induced Liver Damage when Using Cephalosporins. Journal Biomed. 2024;20(3E):244-247. (In Russ.) https://doi.org/10.33647/2713-0428-20-3E-244-247
Views:
91
Email this article 
